ChemicalBook >> CAS DataBase List >>Brolucizumab
Brolucizumab
- CAS No.
- 1531589-13-5
- Chemical Name:
- Brolucizumab
- Synonyms
- Brolucizumab;Research Grade Brolucizumab (DHD12603)
- CBNumber:
- CB58080928
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Last updated:2024-10-28 23:16:16
| FDA UNII | XSZ53G39H5 |
|---|---|
| ATC code | S01LA06 |
Brolucizumab Preparation Products And Raw materials
Raw materials
Preparation Products
Brolucizumab Suppliers
Global( 10)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +8613564774135 | zijue.cai@tsbiochem.com | United States | 19863 | 58 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8011 | 62 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10361 | 58 |
| TargetMol Chemicals Inc. | 4008200310 | marketing@tsbiochem.com | China | 24647 | 58 |
| Biolab Reagents | 027-65279366 18162686757 | products@biolabreagent.com | China | 9818 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 13720134139 | orders@jknbiochem.com | China | 5797 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11974 | 58 |
| Shanghai jerryxing Biomedical Technology Co., Ltd | 17721492509 | 643638326@qq.com | China | 5345 | 58 |
| Changsha Fuzhen Biotechnology Co.，LTD | 13823398779 18670069958 | 3062105966@qq.com | China | 3262 | 58 |
| Olix (Shanghai) Pharmaceutical Technology Co., Ltd | 17316404525 | 209533805@qq.com | China | 9762 | 58 |
View Lastest Price from Brolucizumab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-10-28 | Brolucizumab
1531589-13-5
|
US $247.00-987.00 / mg | 10g | TargetMol Chemicals Inc. |
-
- Brolucizumab
1531589-13-5
- US $247.00-987.00 / mg
- TargetMol Chemicals Inc.
Brolucizumab
Research Grade Brolucizumab (DHD12603)
1531589-13-5